Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02719366 · ClinicalTrials.gov registry record · NA
A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses
A NA study of Presbyopia, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02719366: Completed NA study of Presbyopia, sponsored by CooperVision.
NCT02719366 is a NA study of Presbyopia that has completed, run by CooperVision. The registered enrollment target is 12 participants, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02719366, a NA study of Presbyopia, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.
Primary Outcome
Visual acuity for test and control lens was measured at Distance, Intermediate, and Near conditions by LogMAR.
Conditions Studied
Interventions
- DEVICE comfilcon A Extended Range test lens
- DEVICE comfilcon A control lens
Study Locations (1)
California
- Clinical Research Center, University of California, Berkeley - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02719366 record still lists
NCT02719366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which comfilcon A Extended Range test lens is the first listed.
NCT02719366 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02719366 about?
NCT02719366 is a clinical study titled "A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses". The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.
What is the current status of trial NCT02719366?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-03. Estimated completion is 2016-08.
What conditions does trial NCT02719366 study?
This clinical trial studies the following conditions: Presbyopia.
What interventions are being tested in trial NCT02719366?
The interventions under investigation include: comfilcon A Extended Range test lens (DEVICE), comfilcon A control lens (DEVICE).
Who is sponsoring clinical trial NCT02719366?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02719366 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02719366's enrollment target sits among peer trials
12 39th of 38 the lowest of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia